Opus Genetics (IRD) Short-term Investments (2010 - 2025)
Opus Genetics' (IRD) quarterly Short-term Investments came in at $1000.0 in Q1 2025, down 80.0% year-on-year from $5000.0 in Q1 2024, and down 50.0% on a QoQ basis from $2000.0 in Q4 2024.
Opus Genetics (IRD) Short-term Investments (2010 - 2025) Analysis & Trends
Opus Genetics (IRD) has 15 years of Short-term Investments data on file, last reported at $1000.0 in Q1 2025.
- On a quarterly basis, Short-term Investments fell 80.0% year-over-year to $1000.0 in Q1 2025; TTM through Mar 2025 was $1000.0, a 80.0% decrease from a year earlier, with the FY2024 full-year figure at $2000.0, down 86.67% from the prior year.
- Short-term Investments for Q1 2025 stood at $1000.0, down from $2000.0 in the prior quarter.
- Over the last five years, Short-term Investments for IRD reached as high as $383000.0 in Q3 2021 and fell as low as $1000.0 in Q1 2025.
- Historically, Short-term Investments has averaged $73266.7 across 5 years, with a median of $22000.0 in 2023.
- On a YoY basis, Short-term Investments climbed as much as 69.39% in 2023 and fell as far as 89.11% in 2023.
- Year by year, Short-term Investments stood at $219000.0 in 2021, then sank by 77.63% to $49000.0 in 2022, then plunged by 69.39% to $15000.0 in 2023, then slumped by 86.67% to $2000.0 in 2024, then slumped by 50.0% to $1000.0 in 2025.
- Per Business Quant data, the three most recent Short-term Investments figures were $1000.0 in Q1 2025, $2000.0 in Q4 2024, and $3000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 126,000.00 |
| Mar 31, 2022 | 135,000.00 |
| Dec 31, 2021 | 219,000.00 |
| Sep 30, 2021 | 383,000.00 |
| Dec 31, 2019 | 3.00 Mn |
| Sep 30, 2019 | 5.98 Mn |
| Jun 30, 2019 | 8.95 Mn |
| Mar 31, 2019 | 11.89 Mn |
| Dec 31, 2018 | 5.98 Mn |